Reduced Nuclease Activity of Apurinic/Apyrimidinic Endonuclease ( APE1)Variants on Nucleosomes IDENTIFICATION OF ACCESS RESIDUES

被引:27
|
作者
Hinz, John M. [1 ]
Mao, Peng [1 ]
McNeill, Daniel R. [2 ]
Wilson, David M., III [2 ]
机构
[1] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA
[2] NIA, Lab Mol Gerontol, IRP, NIH, Baltimore, MD 21224 USA
基金
美国国家卫生研究院;
关键词
BASE EXCISION-REPAIR; URACIL-DNA GLYCOSYLASE; GLUCOCORTICOID RESPONSE ELEMENT; CORE PARTICLES; MAJOR HUMAN; BINDING; APE1; ACCESSIBILITY; COORDINATION; PROTEIN;
D O I
10.1074/jbc.M115.665547
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Non-coding apurinic/apyrimidinic (AP) sites are generated at high frequency in genomic DNA via spontaneous hydrolytic, damage-induced or enzyme-mediated base release. AP endonuclease 1 (APE1) is the predominant mammalian enzyme responsible for initiating removal of mutagenic and cytotoxic abasic lesions as part of the base excision repair (BER) pathway. We have examined here the ability of wild-type (WT) and a collection of variant/mutant APE1 proteins to cleave at an AP site within a nucleosome core particle. Our studies indicate that, in comparison to the WT protein and other variant/mutant enzymes, the incision activity of the tumor-associated variant R237C and the rare population variant G241R are uniquely hypersensitive to nucleosome complexes in the vicinity of the AP site. This defect appears to stem from an abnormal interaction of R237C and G241R with abasic DNA substrates, but is not simply due to a DNA binding defect, as the site-specific APE1 mutant Y128A, which displays markedly reduced AP-DNA complex stability, did not exhibit a similar hypersensitivity to nucleosome structures. Notably, this incision defect of R237C and G241R was observed on a pre-assembled DNA glycosylase.AP-DNA complex as well. Our results suggest that the BER enzyme, APE1, has acquired distinct surface residues that permit efficient processing of AP sites within the context of protein-DNA complexes independent of classic chromatin remodeling mechanisms.
引用
收藏
页码:21067 / 21075
页数:9
相关论文
共 50 条
  • [21] Apurinic/apyrimidinic endonuclease APE1 is required for PACAP-induced neuroprotection against global cerebral ischemia
    Stetler, R. Anne
    Gao, Yanqin
    Zukin, R. Suzanne
    Vosler, Peter S.
    Zhang, Lili
    Zhang, Feng
    Cao, Guodong
    Bennett, Michael V. L.
    Chen, Jun
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (07) : 3204 - 3209
  • [22] New oligonucleotide derivatives as unreactive substrate analogues and potential inhibitors of human apurinic/apyrimidinic endonuclease APE1
    Kuznetsov, Nikita A.
    Kupryushkin, Maxim S.
    Abramova, Tatyana V.
    Kuznetsova, Alexandra A.
    Miroshnikova, Anastasia D.
    Stetsenko, Dmitry A.
    Pyshnyi, Dmitrii V.
    Fedorova, Olga S.
    MOLECULAR BIOSYSTEMS, 2016, 12 (01) : 67 - 75
  • [23] Design and Synthesis of 3-Carbamoylbenzoic Acid Derivatives as Inhibitors of Human Apurinic/Apyrimidinic Endonuclease 1 (APE1)
    Aiello, Francesca
    Shabaik, Yumna
    Esqueda, Adrian
    Sanchez, Tino W.
    Grande, Fedora
    Garofalo, Antonio
    Neamati, Nouri
    CHEMMEDCHEM, 2012, 7 (10) : 1825 - 1839
  • [24] Down-regulation of apurinic/apyrimidinic endonuclease 1 ( APE1) in spinal motor neurones under oxidative stress
    Chu, T-H.
    Guo, A.
    Wu, W.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2014, 40 (04) : 435 - 451
  • [25] Inhibition of the human apurinic/apyrimidinic endonuclease (Ape1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone
    Luo, MH
    Kelley, MR
    ANTICANCER RESEARCH, 2004, 24 (04) : 2127 - 2134
  • [26] Identification and Quantification of DNA Repair Protein Apurinic/Apyrimidinic Endonuclease 1 (APE1) in Human Cells by Liquid Chromatography/Isotope-Dilution Tandem Mass Spectrometry
    Kirkali, Gueldal
    Jaruga, Pawel
    Reddy, Prasad T.
    Tona, Alessandro
    Nelson, Bryant C.
    Li, Mengxia
    Wilson, David M., III
    Dizdaroglu, Miral
    PLOS ONE, 2013, 8 (07):
  • [27] Apurinic/Apyrimidinic Endonuclease 1 Is the Essential Nuclease during Immunoglobulin Class Switch Recombination
    Masani, Shahnaz
    Han, Li
    Yu, Kefei
    MOLECULAR AND CELLULAR BIOLOGY, 2013, 33 (07) : 1468 - 1473
  • [28] Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer
    Abdel-Fatah, Tarek M. A.
    Perry, Christina
    Moseley, Paul
    Johnson, Kerstie
    Arora, Arvind
    Chan, Stephen
    Ellis, Ian O.
    Madhusudan, Srinivasan
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 143 (03) : 411 - 421
  • [29] Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties
    Poletto, Mattia
    Malfatti, Matilde C.
    Dorjsuren, Dorjbal
    Scognamiglio, Pasqualina L.
    Marasco, Daniela
    Vascotto, Carlo
    Jadhav, Ajit
    Maloney, David J.
    Wilson, David M., III
    Simeonov, Anton
    Tell, Gianluca
    MOLECULAR CARCINOGENESIS, 2016, 55 (05) : 688 - 704
  • [30] a1-Adrenoceptor agonist methoxamine inhibits base excision repair via inhibition of apurinic/apyrimidinic endonuclease 1 (APE1)
    Kohutova, Aneta
    Münzova, Dita
    Pesl, Martin
    Rotrekl, Vladimir
    ACTA PHARMACEUTICA, 2023, 73 (02) : 281 - 291